Evidence map›Paper›PMID 41258491›Full record

ArticleNature aging2025

Author Correction: A blood-based DNA damage signature in patients with Parkinson's disease is associated with disease progression.

Daisy Sproviero, César Payán-Gómez, Chiara Milanese, Sander Barnhoorn, Shixiang Sun, Akos Gyenis, Domenico Delia, Tammaryn Lashley, Jan H J Hoeijmakers, Jan Vijg and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Daisy Sproviero *IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0001-5061-683X
César Payán-Gómez *Universidad Nacional de Colombia, Sede de La Paz, La Paz, Colombia.
Chiara MilaneseDepartmental Faculty of Medicine and Surgery, UniCamillus-Saint Camillus International University of Health and Medical Sciences, Rome, Italy.ORCID http://orcid.org/0000-0001-8696-2603
Sander BarnhoornDepartment of Molecular Genetics, Erasmus MC, Rotterdam, the Netherlands.
Shixiang SunDepartment of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID http://orcid.org/0000-0001-5499-2963
Akos GyenisInstitute for Genome Stability in Ageing and Disease, Cluster of Excellence for Aging Research, Faculty of Medicine, University of Cologne, Cologne, Germany.
Domenico DeliaIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Tammaryn LashleyThe Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, UK.ORCID http://orcid.org/0000-0001-7389-0348
Jan H J HoeijmakersDepartment of Molecular Genetics, Erasmus MC, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0003-3526-7795
Jan VijgDepartment of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID http://orcid.org/0000-0002-8457-9595
Pier G MastroberardinoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy. piergiorgio.mastroberardino@univaq.it.ORCID http://orcid.org/0000-0003-2364-4258

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41258491
PMCPMC12705430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.